000 | 01973cam a2200385 a 4500 | ||
---|---|---|---|
001 | 436259099 | ||
003 | OSt | ||
005 | 20141025165824.0 | ||
008 | 090902s2011 paua b 001 0 eng | ||
010 | _a2009036522 | ||
016 | 7 |
_a101514404 _2DNLM |
|
020 | _a9780781779340 (alk. paper) | ||
020 | _a0781779340 (alk. paper) | ||
040 | _cSA-DiMC | ||
050 | 0 | 0 |
_aRS200 _b.A57 2011 |
050 | 0 | 0 |
_aRS200 _b.A57 2011 |
060 | 0 | 0 | _a2010 D-258 |
060 | 1 | 0 |
_aQV 785 _bA427a 2011 |
082 | 0 | 0 |
_a615.1 _222 _bANL |
100 | 1 |
_aAllen, Loyd V., _cJr. |
|
245 | 1 | 0 |
_aAnsel's pharmaceutical dosage forms and drug delivery systems / _cLoyd V. Allen Jr., Nicholas G. Popovich, Howard C. Ansel. |
246 | 3 | 0 | _aPharmaceutical dosage forms and drug delivery systems. |
250 | _a9th ed. | ||
260 |
_aPhiladelphia : _bWolters Kluwer Health/Lippincott Williams & Wilkins, _cc2011. |
||
300 |
_aviii, 710 p. : _bill. (some col.) ; _c26 cm. |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aIntroduction to drugs and pharmacy -- New drug development and approval process -- Current good manufacturing practices and current good compounding practices -- Dosage form design : pharmaceutical and formulation considerations -- Dosage form design : biopharmaceutical and pharmacokinetic considerations -- Powders and granules -- Capsules -- Tablets -- Solid oral modified-release dosage forms and drug delivery systems -- Ointments, creams, and gels -- Transdermal drug delivery systems -- Suppositories and inserts -- Solutions -- Disperse systems -- Parenterals -- Biologics -- Special solutions and suspensions -- Radiopharmaceuticals -- Products of biotechnology -- Novel dosage forms and drug delivery technologies. | |
650 | 0 |
_aDrugs _xDosage forms. |
|
650 | 0 | _aDrug delivery systems. | |
650 | 1 | 2 | _aDosage Forms. |
650 | 2 | 2 | _aDrug Delivery Systems. |
700 | 1 | _aPopovich, Nicholas G. | |
700 | 1 |
_aAnsel, Howard C., _d1933- |
|
942 |
_2ddc _cBK |
||
999 |
_c1935 _d1935 |